Annual Report

Overview

The report highlights SMS Pharma's resilient FY22 performance, with consolidated revenue of Rs. 519.87 crore and a 23.0% EBITDA margin. It reports 1,031 employees, 22,600 training hours and safety initiatives. CSR spending reached Rs. 166.20 Lakhs, directed to health, education and rural development. Environmental actions included energy conservation, water recycling and zero-liquid-discharge efforts.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021-2022
Period: 1 April 2021 – 31 March 2022
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services